ARATANA THERAPEUTICS
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.
ARATANA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Leawood, Kansas, United States
Country:
United States
Website Url:
http://www.aratana.com
Total Employee:
51+
Status:
Active
Contact:
913-951-2130
Total Funding:
128.51 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Google Google Maps API Google Cloud Amazon Virginia Region Microsoft GoDaddy
Similar Organizations
7 Hills Pharma
7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bactolife
Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance.
C2Sense
C2Sense, an MIT Engine “Tough Tech” portfolio company, develops advanced sensing solutions for a healthier and safer world
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EVERSANA
EVERSANA is the provider of global services to the life science industry.
GelSana Therapeutics
GelSana Therapeutics develops new products to heal wounds faster.
Generian Pharmaceuticals
Generian has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks.
Gmax Biopharm
Gmax Biopharm dvelope innovative GPCR Antibody therapeutics for unmet medical use.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Journey Colab
Journey Colab pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities.
Korres
Their goal is to develop innovative and effective products based on natural, active ingredients.
VYNE Therapeutics
VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Nutrinia
Nutrinia is developing unique therapies for Intestinal failure patients.
PetSensus
A pet health ecosystem designed for happier, healthier, longer-living pets
Pharmaron
Pharmaron is a research and development service provider for the pharmaceutical industry.
Phyla
Phyla is developing alternative therapies for antibiotics.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Sante Basque Developpement
Sante Basque Developpement is owns and operates mental health hospitals.
Tellus Therapeutics
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-01-06 | Okapi Sciences | Okapi Sciences acquired by Aratana Therapeutics | N/A |
| 2013-10-14 | Vet Therapeutics | Vet Therapeutics acquired by Aratana Therapeutics | N/A |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Aratana Therapeutics
Square 1 Bank
Square 1 Bank investment in Post-IPO Debt - Aratana Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Aratana Therapeutics
Women's Capital Connection
Women's Capital Connection investment in Series C - Aratana Therapeutics
Irv Hockaday
Irv Hockaday investment in Series C - Aratana Therapeutics
Midwest Venture Alliance
Midwest Venture Alliance investment in Series C - Aratana Therapeutics
Kauffman Foundation
Kauffman Foundation investment in Series C - Aratana Therapeutics
Mid-America Angels
Mid-America Angels investment in Series C - Aratana Therapeutics
Middleland Capital
Middleland Capital investment in Series C - Aratana Therapeutics
MPM Capital
MPM Capital investment in Series C - Aratana Therapeutics
